DRRX

DRRX

USD

DURECT Corporation Common Stock

$0.670-0.040 (-5.690%)

Precio en Tiempo Real

Healthcare
Drug Manufacturers - Specialty & Generic
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.710

Máximo

$0.720

Mínimo

$0.632

Volumen

0.00M

Fundamentos de la Empresa

Capitalización de Mercado

21.7M

Industria

Drug Manufacturers - Specialty & Generic

País

United States

Estadísticas de Negociación

Volumen Promedio

0.05M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.63Actual $0.670Máximo $1.88

Noticias Relacionadas

Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Durectto Neutral

HC Wainwright & Co. analyst Ed Arce reiterates Durect from Neutral to Neutral.

Ver más
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
PR Newswire

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided a...

Ver más
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PR Newswire

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated ...

Ver más
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.